PMcardio
Amount undisclosed
Funding date
Valuation / Funding
No funding history available
Funding data has not been imported for this company yet
Current Valuation Metrics
PMcardio is currently valued at N/A as of June 6, 2025. The company has raised a total of $35.9M in funding.
Investment Perspective
PMcardio's valuation reflects investor confidence in the company's market position, growth potential, and ability to execute on its business model. Private market valuations are determined by primary funding rounds and secondary market transactions, which take into account financial performance, market conditions, and growth prospects.
What is PMcardio Worth in 2025?
As of 2025, PMcardio is valued at N/A, based on the company's Accelerator/Incubator funding round in June 6, 2025. This valuation positions PMcardio as one of the leading private companies in the sector.
PMcardio Valuation History
PMcardio's funding history demonstrates steady growth and investor confidence.
How PMcardio Valuation is Determined
Private company valuations like PMcardio's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including:
- Revenue growth and financial performance
- Market opportunity and total addressable market (TAM)
- Competitive positioning and market share
- Management team strength and execution capability
- Technology and intellectual property
- Industry trends and investor sentiment
PMcardio Valuation FAQs
Is PMcardio profitable?
PMcardio has not publicly disclosed its profitability status. Many high-growth private companies prioritize market expansion and user growth over profitability in their early stages.
How does PMcardio's valuation compare to competitors?
PMcardio is valued at N/A, positioning it as a major player in the space. Secondary market pricing and private market transactions provide ongoing validation of this valuation.
When will PMcardio IPO?
PMcardio has not announced plans for an initial public offering. Until an IPO, investors can access PMcardio shares through secondary market platforms.